Corbion NV (CRBN) AI Stock Analysis

• Market Cap: €1.08B
• Dividend Yield: 3.5%
• Average Volume (3M): 126.91K
• Price to Earnings (P/E): 14.4
• Beta (1Y): 0.85
• Revenue Growth: -3.45%
• EPS Growth: -5.55%
• Country: NL
• Employees: 2,383
• Sector: General
• Sector Strength: N/A
• Industry: Chemicals - Specialty
• EPS (TTM): 0.56
• Shares Outstanding: 58,250,310
• 10 Day Avg. Volume: 117,838
• 30 Day Avg. Volume: 126,914
• PEG Ratio: -0.24
• Price to Book (P/B): 1.45
• Price to Sales (P/S): 0.85
• P/FCF Ratio: 11.62
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €22.53
• Price Target Upside: 19.99% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 3
• EPS Forecast (FY): 1.43
• Revenue Forecast (FY): €1.29B

• Rating: 59 Neutral
• Price Target: €20.50 ▲(9.16% Upside)
• Action: Downgraded Date: 03/02/26
• Date: Action: Downgraded 03/02/26

The score is primarily supported by improving financial quality (deleveraging and a sustained rebound to positive free cash flow) and a reasonable valuation with a solid dividend yield. It is held back by weak technicals (price below key short-term averages and oversold momentum) and fundamental headwinds from multi-year revenue softness and uneven net income.

Positive Factors

Specialty B2B ingredient franchise

Corbion's core business supplies lactic-acid–based ingredients and shelf-life solutions to food manufacturers and industrial customers. This B2B, specialty-ingredient model drives structural, repeatable demand, supports higher-margin product mix, and benefits from long qualification cycles that create durable customer relationships.

Negative Factors

Multi-year revenue softness

A multi-year top-line decline erodes operating leverage and constrains the company's ability to grow margins or fund strategic initiatives organically. Persistent revenue weakness increases reliance on cost actions or one-time items to sustain profitability and limits long-term earnings visibility.

Corbion NV Business Overview & Revenue Model

Company Description

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and...

Read more

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and...

How the Company Makes Money

Corbion generates revenue through the sale of its diverse range of food ingredients and biochemical products. The Food Ingredients segment is a significant contributor to its earnings, where the company offers products like emulsifiers, preservati...

Read more

Corbion generates revenue through the sale of its diverse range of food ingredients and biochemical products. The Food Ingredients segment is a significant contributor to its earnings, where the company offers products like emulsifiers, preservati...

Corbion NV Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.27B	1.29B	1.44B	1.46B	1.07B
Gross Profit	330.30M	312.10M	305.40M	324.30M	265.80M
EBITDA	202.30M	172.00M	198.00M	194.00M	140.10M
Net Income	74.80M	192.20M	72.90M	90.00M	78.30M
Balance Sheet
Total Assets	1.42B	1.55B	1.70B	1.72B	1.36B
Cash, Cash Equivalents and Short-Term Investments	44.70M	49.30M	70.20M	58.20M	42.20M
Total Debt	481.10M	509.20M	785.50M	759.20M	503.20M
Total Liabilities	674.30M	773.80M	1.06B	1.10B	806.50M
Stockholders Equity	742.60M	772.50M	636.20M	625.70M	554.10M
Cash Flow
Free Cash Flow	92.70M	99.90M	16.10M	-182.60M	-122.00M
Operating Cash Flow	160.90M	184.10M	165.40M	53.20M	26.70M
Investing Cash Flow	-70.10M	166.00M	-146.80M	-213.30M	-123.70M
Financing Cash Flow	-93.80M	-371.70M	-5.30M	173.90M	85.90M

Corbion NV Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 18.78
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NL:CRBN, the sentiment is Negative. The current price of 18.78 is above the 20-day moving average (MA) of 18.73, below the 50-day MA of 19.74, and above the 200-day MA of 18.29, indicating a neutral trend. The MACD of -0.25 indicates Negative momentum. The RSI at 45.93 is Neutral, neither overbought nor oversold. The STOCH value of 73.54 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NL:CRBN.

Corbion NV Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FFARM	69 Neutral	€566.77M	7.87	14.57%	4.66%	8.76%	193.06%
IMCD	64 Neutral	€5.26B	20.99	10.83%	2.83%	6.09%	-7.18%
AKZA	63 Neutral	€8.39B	4.23	14.61%	3.38%	-2.03%	-89.67%
CRBN	59 Neutral	€1.08B	14.40	8.84%	3.50%	-3.45%	-5.55%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
OCI	47 Neutral	€716.71M	2.88	―	229.25%	―	―
AVTX	46 Neutral	€171.15M	-4.03	-26.08%	―	-12.31%	23.77%